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Abstract: The rapid spread of COVID-19 motivated countries worldwide to mitigate mortality 
through actions including social distancing, home quarantine, school closures, and case isolation. 
We estimate the global mortality benefits of these actions. We use county-level data on COVID-10 
19 from January 2020, project the number of mortalities until September 2020, and calculate the 
global mortality benefits using the age- and country-specific value of a statistical life (VSL). 
Implementing all four types of actions above would save approximately 40.76 trillion USD 
globally, with social distancing accounting for 55% of the benefits. The monetary benefit would 
be the largest in the US, Japan and China. Our findings indicate that global actions during COVID-15 
19 have substantial economic benefits and must be implemented in response to COVID-19. 
Key words: COVID-19; coronavirus; global mortality benefit; value of a statistical life; epidemic 
diseases 
1. Introduction 
1.1. Research Motivation 20 
COVID-19 is a global pandemic that has resulted in 1,484,811 infected cases and 88,538 deaths 
as of April 9, 2020 (WHO), and researchers predict that global mortality will be massive, as in Ji 
et al. (2020) and Remuzzi et al. (2020). Countries worldwide have begun to implement actions to 
mitigate infections and deaths. These actions can be categorized into four types: social distancing, 
home quarantine, school closures, and case isolation. 25 
However, whether these actions are effective in reducing the number of global cases and mortality 
remains unanswered, particularly from a global perspective. Investigating the global perspective 
is crucial, as it would enable countries to collaborate on the next pandemic, as mentioned in Chen 
(2020), Mendes (2020), Ceylan et al. (2020). In other words, questions remain regarding how these 
actions affect the total mortality damage of COVID-19 outside of China, the US, or the UK, which 30 
will be tremendous. Hence, to better design a set of policies that enables the reduction of cases and 
mortalities, this question must be addressed. 
Thus, this study empirically examines the effectiveness of these actions for mitigating loss of 
mortality benefits, which is the monetized value of small changes in the number of mortalities 
aggregated to express the value related to one death in a population (Viscussi and Masterman, 35 
2017). This is a crucial parameter for policy evaluation in the global context. We use county-level 
mortality data on COVID-19 from January 2020, project the number of mortalities until September 
2020, and calculate the global mortality benefits, which is the monetized value of the decreased 
number of mortalities. 
 40 
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1.2. Theoretical Framework 
Our study contributes to two strands of literature. First, it contributes by examining the global 
monetized benefits of mortality during the COVID-19 pandemic. Because maintaining the lowest 
mortality possible should be the highest priority for all governments regardless of borders, our 
results are essential as they provide evidence that global actions during epidemics are essential 5 
because they provide substantial economic benefits that enable countries to mitigate inevitable 
economic downturns. However, we also find that previous works evaluating these actions mainly 
focused on the US, UK, and China. For example, previous works mentioned that these actions 
were effective in China in containing the number of mortalities and infected cases, as in Anderson 
et al. (2020), and reduced peak healthcare demand by 2/3 in the US and UK, as in Ferguson et al. 10 
(2020), which could save 7.9 trillion USD in the US (Greenstone and Nigam, 2020). Furthermore, 
Kraemer et al. (2020) argued that these actions could substantially reduce the number of mortalities 
in Wuhan, China. Thus, we contribute by incorporating countries other than the US, UK, and China 
and by providing global estimates and implications. In this sense, our study is closely related to 
that of Mandel and Veetil (2020), which analyzes the impact of lockdown on the world economy. 15 
Second, our result contributes by calculating the value of lives. Previous research considers diverse 
perspectives on the impact of COVID-19 in various sectors: (Wang, M., & Flessa, S. (2020). It 
computes the spread of the disease and simulates the effects of interventions on health using 
dynamic system models. Govindan et al. (2020) examine how COVID-19 can affect healthcare 
supply systems. Fernandes (2020) investigates how the global economy is affected by comparing 20 
economic conditions during SARS and the 2008-2009 financial crisis. Nakamura and Managi 
(2020) calculate the overall relative risk of the importation and exportation of COVID-19 from 
every airport to local municipalities around the world. While it is also essential to recognize the 
impacts of COVID-19 on diverse sectors, the disease ultimately and closely affects people’s lives. 
Thus, our essential contribution is that we offer an approach for computing quantitative estimates 25 
of the effects of various actions on the value of lives. Therefore, it is relatively easy to understand 
which actions are more effective in reducing the cases and mortalities. 
The remainder of this paper is structured as follows. Section 1 provides background in terms of 
policy, and Section 2 presents the model and introduces the data used in this study. Section 3 shows 
the empirical results. Section 4 discusses practical implications, and Section 5 concludes. 30 
2. Methodology 
2.1. Scenario Settings 
We establish two scenarios before computing the number of mortalities and the global mortality 
benefits. First, we establish a scenario involving the most aggressive form of social distancing, 
with all four additional actions included (social distancing, home quarantine, closure of schools, 35 
and case isolation), as the Action Scenario. We establish another scenario, the Nonaction Scenario, 
which does not include any of the actions included in the Action Scenario and depends on a form 
of “herd immunity.” The Nonaction Scenario does not mean that a country is not taking any actions 
to mitigate mortalities. Instead, it refers to a hypothetical situation in which countries are not 
implementing the four actions above.1 We assume that all measures started in late March and that 40 
COVID-19 will persist until late September. Then, we compare the projected number of mortalities 
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and global mortality benefits of the two scenarios to draw implications on the monetized benefits 
of executing all four actions. 
2.2. Empirical Analysis 
Computing the global mortality benefits starts with projecting the global number of 
mortalities. To do so, we refer to the transmission model and health care demand from Ferguson 5 
et al. (2020) and Greenstone and Nigam (2020) using basic reproduction numbers with country-
level data. We develop a model that predicts the daily number of infected cases and mortalities 
under simple assumptions. First, we assume that the number of infected cases and mortalities 
follows the normal distribution, which approximates the growth curves for the epidemic. The 
center or peak of the distribution, for instance, would correspond to the peak of the daily number 10 
of new infected cases. Then, we compute the number of mortalities based on the number of 
projected infected cases and the infection fatality ratio (IFR) from Verity et al. (2020) To acquire 
the number of mortalities based on age group, we adjust for the age distribution of each country, 
referring to World Bank data. We determine nine age groups and their distributions for each 
country, and we adopt the same distribution for the total number of mortalities. Using the number 15 
of mortalities, we calculate the reduction in mortality from the Nonaction Scenario to the Action 
Scenario and compute the global mortality benefit using age-varying and country-specific 
estimates of the value of a statistical life (VSL), referring to Greenstone and Nigam (2020), Viscusi 
and Masterman (2020), Jumbri et al. (2018), and Murphy and Topel (2006).2 
Our model calculates direct deaths with a simple model structure instead of directly 20 
including intensive care unit (ICU) bed demand overflow. As a result of this simple structure and 
the many places that are currently replacing the ICU in practice globally, our model is applicable 
to discussions of important social aspects with a focus on the direct number of mortalities. 
Ferguson et al. (2020) and Greenstone and Nigam (2020) apply a more complex model by adopting 
the demand overflow of ICU beds, but this would require more assumptions, and the number of 25 
assumptions would increase if we broadened the research scope to include the entire world. 
First, the demand for ICU beds is subject to change. For the Chinese data on ICUs, 
clinicians noted that only half of the patients seemed to need invasive mechanical ventilators; the 
others were given pressurized oxygen and may not have needed an ICU bed, as mentioned in Adam 
(2020). Furthermore, the demand for ICU beds is subject to change according to the efficiency of 30 
bed management in hospitals, as in Davie et al. (2005). Second, ICU beds are not available in low-
income countries (i.e., Cambodia, Congo, Ethiopia, Kenya, Nepal, and Uganda). These low-
income countries lack ICU beds, and more than 50% of these countries lack any published data on 
ICU capacity, as mentioned in (Murthy et al., 2015). Third, referring to Onuma et al. (2017), as 
the pandemic persists, countries increase their adaptation capability, which works globally to 35 
reduce adverse effects (i.e., mortalities) in general. Increased adaptation capability would reduce 
ICU bed demand, requiring more complex assumptions, whereas we focus on implications in the 
simple but global context. Therefore, in this study, we focus on the number of direct deaths and 
discuss global implications. 
3. Results 40 
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Our calculated global mortality benefit shows that adopting the most aggressive form of action 
would save approximately USD 40.76 trillion globally. Considering that the global GDP in 2018 
was approximately 85.91 trillion USD (World Bank), our results show a savings of approximately 
47.44% of the GDP as a result of taking action. This result indicates that world populations are 
willing to pay USD 40.76 trillion for mortality risk reductions. Our results also show that social 5 
distancing has the most substantial effects of saving USD 14.79 trillion for mortality risk 
reductions, which is 17.22% of the global GDP. 
 
Figure 1 Panel (A): Global Distribution of Global Mortality Benefits (in Trillion USD) A higher number (blue color) indicates that 
the benefits of actions (case isolation, home quarantine, school closure and social distancing) are high. Lower values (green colors) 10 
suggest that the estimated mortality benefit is lower. Panel (B): GDP Loss after COVID-19 in the Nonaction Scenario (%). A higher 
number indicates that the GDP loss is high. Lower values suggest that the estimated GDP loss is low. 
Panel (A) in Figure 1 shows the global distribution of global mortality benefits through a map. Our 
estimates suggest that the US would share the most benefit, approximately 17.71%, at the continent 
level. At the country level, Japan and China would benefit the most, as they share 12.64% and 15 
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11.96%, respectively, of the benefits of avoided damages worldwide. European countries also 
receive a large portion of the benefits: Germany has the highest savings, with 7.92%, followed by 
France (5.20%), the UK (5.00%), and Italy (4.37%). On the other hand, countries with the least 
benefits are mainly those on the African continent, for example, Gambia, Central African Republic, 
and Rwanda. Panel (B) in Figure 1 indicates the global distribution of GDP loss due to nonaction. 5 
We calculate the GDP loss by calculating the global mortality benefit before the COVID-19 
outbreak and then subtract it from the global mortality benefit after the COVID-19 outbreak. Then, 
we divide the difference between the two by the GDP. In Panel (A), our results indicate that the 
global average of GDP loss would be 35.61%. Global loss due to nonaction was highest in Japan 
and European countries and low in African countries. One interesting finding here is that, while 10 
the US shows a relatively high global mortality benefit in Panel (A), our estimates suggest that the 
GDP loss after COVID-19 in the US would also be substantial (34.61%). 
 Figure 2 Global Mortality Benefits by Action, expressed in trillion USD. The label on the bar graph refers to the monetized 
value of each action. For example, social distancing shows a global mortality benefit of 14.79 trillion USD. 15 
Figure 2 shows the distribution of global mortality benefits by action. Among all types of actions, 
social distancing has the most significant benefits. Social distancing accounts for 55% of the 
benefit (USD 14.71 trillion), followed by home quarantine, school closures, and case isolation, 
which account for 23% (USD 6.08 trillion), 21% (USD 5.59 trillion), and 2% (USD 0.49 trillion), 
respectively. Our findings are consistent with Ferguson and Greenstone, who show that the 20 
benefits of social distancing are substantial. However, this is not to say that other actions are a 
futile endeavor; given a choice between nonaction and action, countries worldwide would prefer 
to take action. Therefore, there is still a need to promote actions that yield lower benefits than 
social distancing. 
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Figures 3, 4, and 5 show the portion of global benefits for national GDP by country and scenario, 
expressed in maps; the projected number of mortalities by country and scenario; and the GDP loss 
of action scenarios, respectively. Panel (A) shows the result of Action Scenario 1, which includes 
case isolation, home quarantine, and social distancing; Panel (B) displays the result of Action 
Scenario 2, which includes school closure, case isolation, and social distancing; Panel (C) presents 5 
the result of Action Scenario 3, which includes case isolation, school closure, home quarantine, 
and social distancing. We further provide the specific rankings for each figure in Appendix Tables 
A1, A2 and A3. 
Regarding age group, the 60- to 69-year-old age group would experience the most benefits, at 
21.70%; the 50- to 59-year age group would experience 7.42%; and 40- to 49-year-olds would 10 
experience 1.92%. This result shows that the number of cases, the number of deaths and the 
willingness to pay to reduce risk to life are higher for the 60- to 69-year-old age group than for the 
other age groups. 
 
 7 
 
 Figure 3 The Portion of Global Benefits for National GDP by Country and Scenario, Expressed in Maps. 
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 Figure 4 The Projected Number of Mortalities by Country and Scenario, Expressed in Maps (Projected until Late September). 
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 Figure 5 The GDP Loss of Action Scenarios by Countries and Scenarios Expressed in Maps. 
 
4. Discussion 
The estimates for each country are worth highlighting. First, we find that the overall benefits are 5 
focused on developed countries. The top 10 countries with the greatest benefits include the US, 
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Japan, China, Germany, France, and the UK. The total global mortality of the top 3 countries (the 
US, Japan, and China) would be 16.78 trillion USD, which is more than 40% of the total global 
mortality benefits and accounts for approximately 20% of the global GDP for 2018. Such vast 
benefits cannot be easily derived from policy interventions, which implies that the economic 
benefits of taking actions are substantial. This result also suggests that the people in these three 5 
countries value their lives and are therefore willing to pay a large amount of money to reduce risks. 
Second, the bottom ten countries with the least benefits include Gambia, the Central African 
Republic, Liberia, Rwanda, and Togo (all less than 1%), which are mainly situated on the African 
continent. This result is due to the small number of cases in Africa until late March. It is 
questionable whether African countries have fewer cases than Europe or Asia because African 10 
countries do not have the medical capability to count confirmed cases. Because of the high volume 
of air traffic and trade between China and Africa, Africa is at high risk for the introduction and 
spread of COVID-19, as mentioned in Nkengasong et al. (2020). Martinez-Alvarez et al. (2020) 
mentioned that once the first cases were confirmed in West Africa, the increase in the number of 
confirmed cases of COVID-19 was rapid. However, Wang et al. (2020) and Bukhari and Jameel 15 
(2020) argue that Africa should be safer from COVID-19 because its high temperature and 
humidity can reduce the number of cases. If the virus that causes COVID-2019 is weakened by 
warm temperatures, then the environmental factors of countries with high temperatures and 
humidity can maximize the benefits of social distancing and can further prevent cases and deaths. 
However, other strands of research, including Xie et al. (2020) and Breton (2020), argue that 20 
temperature is not correlated with the sensitivity of COVID-19. 
From a policy perspective, it is necessary to keep the public informed of the benefits of actions in 
terms of reducing cases and mortalities and maximizing global economic benefits. Actions, 
including social distancing, home quarantine, school closure and case isolation, are vital not only 
for global mortality benefits but also for preventing mortality and GDP loss. In this case, to 25 
maximize the benefits and mitigate cases and deaths, raising awareness of social distancing is 
required. Because this is a benefit-of-life value, which is challenging to monetize, there is room 
for our estimates to be increased if pandemics persist and people place more importance on the 
value of a life over this time, as in Liu et al. (2005). 
In this sense, our estimates are not overestimated; they are likely to represent the lower bound and 30 
leave room to increase because we did not consider additional benefits derived from social 
distancing. For example, Sen-Crowe et al. (2020) argue that social distancing can slow infection 
and can further reduce cases and improve the quality of medical care for non-COVID-19 symptoms. 
Our results are not limited to social distancing and highlight the importance of other measures. 
Measures such as school closure or home quarantine could be more feasible than social distancing 35 
measures, as in Fong et al. (2020). Pandemic plans need to consider how to facilitate such efforts 
because multiple actions would maximize the benefits and save more lives worldwide. 
5. Conclusion 
The COVID-19 outbreak indicates the need to evaluate the actions that governments worldwide 
are implementing to mitigate the number of mortalities and cases. The impact of these actions on 40 
the worldwide economy is estimated to be substantial. Our estimates suggest that at least 40.76 
trillion USD can be saved globally. Economic loss due to reduced demand and supply as a result 
of COVID-19 has been discussed, but we show that reducing the loss of humans would be more 
significant because the total saved loss would be approximately 47.28% of the global annual GDP. 
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Social distancing accounts for more than half of the estimates and would save 14.49 trillion USD 
globally. This amount is larger than the Chinese GDP and equivalent to approximately 2/3 of the 
US GDP. Our results show that these actions can produce substantial benefits worldwide. 
Unfortunately, predicting the global mortality benefits a few months after the outbreak of COVID-
19 does include the problem of uncertainty. However, we believe this research will provide 5 
guidelines and insights for researchers and policymakers by providing humble policy advice. 
Estimating more robust estimates with more data and over a longer period would boost the 
numerical precision of this research and should be a focus of future research. 
 
Appendix 10 
In this section, we provide the results tables for Figures 3, 4 and 5. 
Table A1. 
Table A1. Portion of Global Benefits to National GDP by Country and Scenario. (A): A list of the countries 
included in this study (alphabetical order). (B-a): The portion of benefits to the national GDP by country for Action 
Scenario 1, which includes case isolation, home quarantine, and social distancing. (B-b): The portion of benefits to 15 
the national GDP by country for Action Scenario 2, which includes school closure, case isolation, and social 
distancing. (B-c): The portion of benefits to the national GDP by country for Action Scenario 3, which includes 
case isolation, school closure, home quarantine, and social distancing. 
 
(A) Countries (B) Benefits from Actions (% to National GDP) 
 (B-a) Action Scenario 1 (B-b) Action Scenario 2 (B-c) Action Scenario 3 
Afghanistan 11.40% 13.30% 13.40% 
Albania 38.10% 44.20% 44.80% 
Algeria 27.20% 31.60% 32.00% 
Angola 10.60% 12.30% 12.40% 
Antigua and Barbuda 27.90% 32.40% 32.80% 
Argentina 39.20% 45.50% 46.00% 
Armenia 37.60% 43.60% 44.20% 
Australia 54.40% 63.10% 63.90% 
Austria 58.40% 67.80% 68.60% 
Azerbaijan 35.30% 41.00% 41.50% 
Bahamas 17.10% 19.90% 20.10% 
Bahrain 10.80% 12.50% 12.70% 
Bangladesh 13.80% 16.10% 16.30% 
Barbados 44.30% 51.40% 52.10% 
Belarus 51.70% 60.00% 60.80% 
Belgium 58.50% 67.90% 68.70% 
Belize 16.40% 19.10% 19.30% 
Benin 11.00% 12.80% 12.90% 
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Bhutan 15.90% 18.50% 18.70% 
Bolivia 21.30% 24.70% 25.00% 
Bosnia and Herzegovina 42.60% 49.50% 50.10% 
Brazil 33.10% 38.40% 38.90% 
Brunei Darussalam 24.20% 28.10% 28.50% 
Bulgaria 52.60% 61.00% 61.70% 
Burkina Faso 8.10% 9.50% 9.60% 
Cambodia 11.90% 13.80% 13.90% 
Cameroon 8.60% 10.00% 10.10% 
Canada 59.20% 68.80% 69.60% 
Central African Republic 7.10% 8.20% 8.30% 
Chad 10.90% 12.60% 12.80% 
Chile 35.60% 41.30% 41.80% 
China 30.50% 35.40% 35.80% 
Colombia 32.50% 37.70% 38.20% 
Congo 12.50% 14.50% 14.70% 
Costa Rica 30.00% 34.80% 35.30% 
Côte d'Ivoire 8.60% 10.00% 10.10% 
Croatia 56.80% 66.00% 66.80% 
Cyprus 56.90% 66.10% 66.90% 
Czech Republic 47.30% 54.90% 55.60% 
Democratic Republic of the Congo 7.90% 9.20% 9.30% 
Denmark 59.90% 69.50% 70.40% 
Dominican Republic 20.10% 23.40% 23.70% 
Ecuador 24.40% 28.30% 28.70% 
Egypt 24.10% 28.00% 28.30% 
El Salvador 27.90% 32.30% 32.70% 
Equatorial Guinea 11.70% 13.60% 13.80% 
Estonia 51.00% 59.20% 60.00% 
Ethiopia 9.50% 11.00% 11.20% 
Fiji 15.40% 17.90% 18.10% 
Finland 64.10% 74.40% 75.30% 
France 64.90% 75.40% 76.30% 
Gabon 15.10% 17.50% 17.70% 
Gambia 6.00% 7.00% 7.10% 
Georgia 43.40% 50.30% 50.90% 
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Germany 69.60% 80.80% 81.80% 
Ghana 8.20% 9.50% 9.60% 
Greece 74.10% 86.00% 87.10% 
Grenada 26.30% 30.50% 30.90% 
Guatemala 13.80% 16.00% 16.20% 
Guinea 5.50% 6.40% 6.50% 
Guyana 20.20% 23.50% 23.80% 
Haiti 16.50% 19.20% 19.40% 
Honduras 16.20% 18.80% 19.00% 
Hungary 48.70% 56.50% 57.20% 
Iceland 33.40% 38.80% 39.30% 
India 2.50% 3.00% 3.00% 
Indonesia 19.70% 22.80% 23.10% 
Iran 27.00% 31.30% 31.70% 
Iraq 12.10% 14.10% 14.20% 
Ireland 30.60% 35.60% 36.00% 
Israel 33.40% 38.80% 39.30% 
Italy 72.80% 84.50% 85.50% 
Jamaica 29.20% 33.80% 34.30% 
Japan 88.20% 102.40% 103.70% 
Jordan 16.40% 19.00% 19.20% 
Kazakhstan 31.50% 36.60% 37.10% 
Kenya 7.70% 8.90% 9.00% 
Kuwait 19.20% 22.30% 22.60% 
Kyrgyzstan 16.30% 18.90% 19.10% 
Laos 10.40% 12.10% 12.30% 
Latvia 55.20% 64.00% 64.80% 
Lebanon 24.20% 28.10% 28.50% 
Liberia 6.70% 7.80% 7.90% 
Lithuania 52.60% 61.00% 61.80% 
Luxembourg 31.80% 36.90% 37.40% 
Madagascar 9.10% 10.50% 10.70% 
Malaysia 22.70% 26.30% 26.60% 
Maldives 9.80% 11.40% 11.60% 
Mali 7.60% 8.80% 8.90% 
Malta 53.00% 61.50% 62.20% 
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Mauritania 13.70% 15.90% 16.10% 
Mauritius 34.70% 40.20% 40.70% 
Mexico 26.30% 30.50% 30.90% 
Mongolia 15.90% 18.50% 18.70% 
Montenegro 39.90% 46.30% 46.80% 
Morocco 23.60% 27.50% 27.80% 
Mozambique 12.10% 14.10% 14.20% 
Myanmar 18.80% 21.80% 22.10% 
Namibia 11.60% 13.40% 13.60% 
Nepal 13.70% 15.90% 16.10% 
Netherlands 58.00% 67.30% 68.10% 
New Zealand 49.60% 57.60% 58.30% 
Nicaragua 19.20% 22.20% 22.50% 
Niger 8.60% 10.00% 10.10% 
Nigeria 13.90% 16.10% 16.30% 
Norway 63.60% 73.90% 74.80% 
Oman 11.90% 13.80% 13.90% 
Pakistan 15.20% 17.60% 17.80% 
Panama 22.40% 26.00% 26.30% 
Papua New Guinea 10.70% 12.40% 12.50% 
Paraguay 16.30% 18.90% 19.10% 
Peru 25.70% 29.90% 30.20% 
Philippines 22.10% 25.60% 25.90% 
Poland 50.70% 58.80% 59.50% 
Portugal 64.00% 74.30% 75.20% 
Puerto Rico 40.60% 47.10% 47.70% 
Qatar 12.50% 14.50% 14.60% 
Republic of Korea 46.10% 53.50% 54.10% 
Romania 46.30% 53.80% 54.40% 
Russian Federation 50.10% 58.10% 58.80% 
Rwanda 10.30% 12.00% 12.10% 
Saint Lucia 23.60% 27.40% 27.80% 
Saint Vincent and the Grenadines 29.50% 34.30% 34.70% 
Saudi Arabia 14.90% 17.20% 17.50% 
Senegal 7.10% 8.30% 8.40% 
Serbia 43.30% 50.20% 50.80% 
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Seychelles 26.20% 30.40% 30.80% 
Singapore 34.80% 40.40% 40.90% 
Slovakia 46.30% 53.70% 54.40% 
Slovenia 55.30% 64.20% 64.90% 
South Africa 18.10% 21.00% 21.20% 
Spain 62.60% 72.60% 73.50% 
Sri Lanka 32.80% 38.10% 38.50% 
Sudan 25.50% 29.60% 30.00% 
Suriname 37.40% 43.40% 44.00% 
Sweden 67.70% 78.60% 79.50% 
Switzerland 63.80% 74.10% 75.00% 
Thailand 34.00% 39.50% 40.00% 
Timor Leste 16.00% 18.60% 18.80% 
Togo 8.50% 9.90% 10.00% 
Trinidad and Tobago 38.10% 44.30% 44.80% 
Tunisia 34.50% 40.10% 40.60% 
Turkey 31.80% 36.90% 37.30% 
Uganda 8.40% 9.70% 9.80% 
Ukraine 48.50% 56.30% 57.00% 
United Arab Emirates 9.50% 11.10% 11.20% 
United Kingdom 60.70% 70.50% 71.30% 
United States of America 28.00% 32.50% 32.90% 
Uruguay 45.30% 52.60% 53.20% 
Uzbekistan 25.50% 29.60% 30.00% 
Vietnam 22.10% 25.60% 25.90% 
Zambia 8.10% 9.40% 9.50% 
Zimbabwe 4.40% 5.10% 5.10% 
 
Table A2 
Table A2. Projected Number of Mortality by Country and Scenario (Projected until Late September). (A): A 
list of the countries included in this study (alphabetical order). (B-a): The number of projected mortalities in the 
Nonaction scenario until late September. (B-b): The number of projected mortalities in Action Scenario 1, which 5 
includes case isolation, school closure, and social distancing. (B-c): The number of projected mortalities in Action 
Scenario 2, which includes school closure, case isolation, and social distancing. (B-d): The number of projected 
mortalities in Action Scenario 3, which includes case isolation, school closure, home quarantine, and social distancing. 
 
(A) Countries  (B) Projected Number of Mortalities 
 (B-a) Nonaction (B-b) Action Scenario 1 (B-c) Action Scenario 2 (B-d) Action Scenario 3 
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Afghanistan 25,353 4,325 943 646 
Albania 9,423 1,608 351 240 
Algeria 67,963 11,595 2,528 1,732 
Angola 18,650 3,182 694 475 
Antigua and Barbuda 238 41 9 6 
Argentina 114,454 19,526 4,258 2,917 
Armenia 8,434 1,439 314 215 
Australia 90,968 15,519 3,384 2,319 
Austria 39,271 6,700 1,461 1,001 
Azerbaijan 17,680 3,016 658 451 
Bahamas 718 122 27 18 
Bahrain 1,436 245 53 37 
Bangladesh 222,920 38,030 8,293 5,682 
Barbados 1,101 188 41 28 
Belarus 33,471 5,710 1,245 853 
Belgium 50,242 8,571 1,869 1,281 
Belize 479 82 18 12 
Benin 9,448 1,612 351 241 
Bhutan 1,148 196 43 29 
Bolivia 20,024 3,416 745 510 
Bosnia and Herzegovina 12,899 2,201 480 329 
Brazil 446,933 76,247 16,626 11,392 
Brunei Darussalam 606 103 23 15 
Bulgaria 32,061 5,470 1,193 817 
Burkina Faso 12,577 2,146 468 321 
Cambodia 19,059 3,252 709 486 
Cameroon 17,617 3,006 655 449 
Canada 149,584 25,519 5,565 3,813 
Central African Republic 3,311 565 123 84 
Chad 9,756 1,664 363 249 
Chile 52,720 8,994 1,961 1,344 
China 3,666,538 625,511 136,395 93,460 
Colombia 105,512 18,000 3,925 2,690 
Congo 3,884 663 144 99 
Costa Rica 12,155 2,074 452 310 
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Côte d'Ivoire 18,308 3,123 681 467 
Croatia 19,121 3,262 711 487 
Cyprus 3,830 653 142 98 
Czech Republic 44,795 7,642 1,666 1,142 
Democratic Republic of the 
Congo 63,435 10,822 2,360 1,617 
Denmark 25,489 4,348 948 650 
Dominican Republic 19,333 3,298 719 493 
Ecuador 30,740 5,244 1,144 784 
Egypt 126,645 21,606 4,711 3,228 
El Salvador 12,901 2,201 480 329 
Equatorial Guinea 858 146 32 22 
Estonia 5,984 1,021 223 153 
Ethiopia 94,512 16,124 3,516 2,409 
Fiji 1,239 211 46 32 
Finland 26,691 4,554 993 680 
France 311,641 53,166 11,593 7,944 
Gabon 1,928 329 72 49 
Gambia 1,493 255 56 38 
Georgia 12,844 2,191 478 327 
Germany 419,026 71,486 15,588 10,681 
Ghana 25,223 4,303 938 643 
Greece 55,712 9,504 2,072 1,420 
Grenada 252 43 9 6 
Guatemala 21,047 3,591 783 536 
Guinea 8,957 1,528 333 228 
Guyana 1,342 229 50 34 
Haiti 13,848 2,362 515 353 
Honduras 11,931 2,035 444 304 
Hungary 41,499 7,080 1,544 1,058 
Iceland 1,208 206 45 31 
India 308,140 52,569 11,463 7,854 
Indonesia 417,010 71,142 15,513 10,630 
Iran 132,261 22,564 4,920 3,371 
Iraq 32,632 5,567 1,214 832 
Ireland 15,618 2,664 581 398 
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Israel 24,261 4,139 903 618 
Italy 323,881 55,254 12,048 8,256 
Jamaica 6,354 1,084 236 162 
Japan 791,482 135,027 29,443 20,175 
Jordan 10,346 1,765 385 264 
Kazakhstan 34,781 5,934 1,294 887 
Kenya 35,100 5,988 1,306 895 
Kuwait 4,494 767 167 115 
Kyrgyzstan 7,902 1,348 294 201 
Laos 7,545 1,287 281 192 
Latvia 8,879 1,515 330 226 
Lebanon 12,464 2,126 464 318 
Liberia 4,050 691 151 103 
Lithuania 13,174 2,248 490 336 
Luxembourg 2,052 350 76 52 
Madagascar 21,000 3,583 781 535 
Malaysia 53,815 9,181 2,002 1,372 
Maldives 528 90 20 13 
Mali 11,902 2,030 443 303 
Malta 2,257 385 84 58 
Mauritania 3,665 625 136 93 
Mauritius 3,529 602 131 90 
Mexico 231,554 39,503 8,614 5,902 
Mongolia 3,763 642 140 96 
Montenegro 2,129 363 79 54 
Morocco 64,494 11,003 2,399 1,644 
Mozambique 20,997 3,582 781 535 
Myanmar 80,548 13,742 2,996 2,053 
Namibia 2,261 386 84 58 
Nepal 38,071 6,495 1,416 970 
Netherlands 75,977 12,962 2,826 1,937 
New Zealand 17,789 3,035 662 453 
Nicaragua 9,066 1,547 337 231 
Niger 14,348 2,448 534 366 
Nigeria 137,381 23,437 5,111 3,502 
Norway 20,650 3,523 768 526 
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Oman 3,890 664 145 99 
Pakistan 231,799 39,545 8,623 5,909 
Panama 8,577 1,463 319 219 
Papua New Guinea 7,845 1,338 292 200 
Paraguay 11,021 1,880 410 281 
Peru 65,248 11,131 2,427 1,663 
Philippines 143,944 24,557 5,355 3,669 
Poland 155,862 26,590 5,798 3,973 
Portugal 52,588 8,972 1,956 1,340 
Puerto Rico 14,894 2,541 554 380 
Qatar 1,988 339 74 51 
Republic of Korea 190,499 32,499 7,087 4,856 
Romania 81,846 13,963 3,045 2,086 
Russian Federation 507,695 86,613 18,886 12,941 
Rwanda 9,843 1,679 366 251 
Saint Lucia 433 74 16 11 
Saint Vincent and the 
Grenadines 253 43 9 6 
Saudi Arabia 34,737 5,926 1,292 885 
Senegal 12,267 2,093 456 313 
Serbia 27,688 4,724 1,030 706 
Seychelles 198 34 7 5 
Singapore 17,034 2,906 634 434 
Slovakia 19,537 3,333 727 498 
Slovenia 9,427 1,608 351 240 
South Africa 76,677 13,081 2,852 1,954 
Spain 218,112 37,210 8,114 5,560 
Sri Lanka 53,721 9,165 1,998 1,369 
Sudan 37,994 6,482 1,413 968 
Suriname 1,005 172 37 26 
Sweden 45,528 7,767 1,694 1,161 
Switzerland 37,248 6,355 1,386 949 
Thailand 210,553 35,920 7,833 5,367 
Timor Leste 1,326 226 49 34 
Togo 5,890 1,005 219 150 
Trinidad and Tobago 3,605 615 134 92 
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Tunisia 24,208 4,130 901 617 
Turkey 172,502 29,429 6,417 4,397 
Uganda 23,034 3,930 857 587 
Ukraine 168,541 28,753 6,270 4,296 
United Arab Emirates 6,416 1,095 239 164 
United Kingdom 279,866 47,745 10,411 7,134 
United States of America 731,068 124,720 27,196 18,635 
Uruguay 12,033 2,053 448 307 
Uzbekistan 41,694 7,113 1,551 1,063 
Vietnam 190,620 32,520 7,091 4,859 
Zambia 10,107 1,724 376 258 
Zimbabwe 11,004 1,877 409 280 
 
Table A3. 
Table A3. GDP Loss of Action Scenarios by Countries and Scenarios Expressed in Table. (A): A list of countries 
included in this study (alphabetical order). (B-a): The GDP loss from the Nonaction Scenario. (B-b): The GDP loss of 
Action Scenario 1, which includes case isolation, home quarantine, and social distancing. (B-c): The GDP loss of 5 
Action Scenario 2, which includes school closure, case isolation, and social distancing. (B-d): the GDP loss of Action 
Scenario 3, which includes case isolation, school closure, home quarantine, and social distancing. 
 
(A) Countries (B) GDP Loss (% of National GDP) 
 (B-a) Nonaction (B-b) Action Scenario 1 (B-c) Action Scenario 2 (B-d) Action Scenario 3 
Afghanistan 13.787% 2.350% 0.514% 0.351% 
Albania 45.936% 7.836% 1.710% 1.172% 
Algeria 32.807% 5.596% 1.220% 0.836% 
Angola 12.726% 2.171% 0.473% 0.325% 
Antigua and Barbuda 33.689% 5.747% 1.252% 0.859% 
Argentina 47.221% 8.056% 1.756% 1.203% 
Armenia 45.327% 7.733% 1.687% 1.156% 
Australia 65.582% 11.190% 2.441% 1.672% 
Austria 70.370% 12.005% 2.618% 1.794% 
Azerbaijan 42.550% 7.258% 1.583% 1.084% 
Bahamas 20.625% 3.519% 0.768% 0.526% 
Bahrain 12.992% 2.217% 0.483% 0.331% 
Bangladesh 16.690% 2.846% 0.620% 0.425% 
Barbados 53.432% 9.116% 1.987% 1.361% 
Belarus 62.342% 10.635% 2.320% 1.589% 
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Belgium 70.484% 12.024% 2.622% 1.797% 
Belize 19.795% 3.377% 0.735% 0.503% 
Benin 13.263% 2.262% 0.493% 0.338% 
Bhutan 19.212% 3.277% 0.714% 0.489% 
Bolivia 25.665% 4.379% 0.956% 0.654% 
Bosnia and 
Herzegovina 
51.383% 8.767% 1.912% 1.309% 
Brazil 40.658% 6.936% 1.512% 1.036% 
Brunei Darussalam 29.215% 4.984% 1.087% 0.744% 
Bulgaria 63.361% 10.810% 2.358% 1.615% 
Burkina Faso 9.825% 1.676% 0.365% 0.250% 
Cambodia 14.306% 2.441% 0.532% 0.365% 
Cameroon 10.368% 1.769% 0.385% 0.264% 
Canada 71.421% 12.185% 2.658% 1.821% 
Central African 
Republic 
8.527% 1.454% 0.317% 0.218% 
Chad 13.113% 2.235% 0.486% 0.333% 
Chile 42.898% 7.318% 1.595% 1.093% 
China 36.763% 6.272% 1.368% 0.937% 
Colombia 39.158% 6.679% 1.457% 0.998% 
Congo 15.108% 2.577% 0.562% 0.386% 
Costa Rica 36.178% 6.172% 1.345% 0.921% 
Côte d'Ivoire 10.415% 1.778% 0.388% 0.266% 
Croatia 68.530% 11.691% 2.549% 1.747% 
Cyprus 68.618% 11.708% 2.554% 1.751% 
Czech Republic 57.020% 9.728% 2.120% 1.453% 
Democratic Republic 
of the Congo 
9.564% 1.631% 0.356% 0.244% 
Denmark 72.198% 12.318% 2.687% 1.841% 
Dominican Republic 24.286% 4.144% 0.904% 0.619% 
Ecuador 29.427% 5.020% 1.094% 0.749% 
Egypt 29.061% 4.958% 1.081% 0.740% 
El Salvador 33.588% 5.732% 1.251% 0.858% 
Equatorial Guinea 14.132% 2.410% 0.525% 0.359% 
Estonia 61.522% 10.496% 2.289% 1.568% 
Ethiopia 11.452% 1.954% 0.426% 0.292% 
Fiji 18.610% 3.175% 0.692% 0.474% 
Finland 77.256% 13.179% 2.873% 1.969% 
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France 78.273% 13.354% 2.911% 1.995% 
Gabon 18.150% 3.097% 0.676% 0.466% 
Gambia 7.245% 1.236% 0.270% 0.186% 
Georgia 52.269% 8.918% 1.945% 1.332% 
Germany 83.908% 14.314% 3.121% 2.138% 
Ghana 9.831% 1.678% 0.366% 0.252% 
Greece 89.341% 15.242% 3.324% 2.277% 
Grenada 31.663% 5.402% 1.178% 0.808% 
Guatemala 16.598% 2.832% 0.618% 0.423% 
Guinea 6.670% 1.138% 0.249% 0.170% 
Guyana 24.379% 4.159% 0.907% 0.622% 
Haiti 19.951% 3.402% 0.742% 0.509% 
Honduras 19.535% 3.333% 0.728% 0.499% 
Hungary 58.702% 10.015% 2.184% 1.496% 
Iceland 40.280% 6.872% 1.498% 1.027% 
India 3.127% 0.533% 0.117% 0.080% 
Indonesia 23.706% 4.044% 0.881% 0.603% 
Iran 32.534% 5.550% 1.211% 0.831% 
Iraq 14.598% 2.490% 0.544% 0.373% 
Ireland 36.949% 6.304% 1.374% 0.941% 
Israel 40.308% 6.877% 1.499% 1.028% 
Italy 87.745% 14.969% 3.263% 2.236% 
Jamaica 35.157% 5.998% 1.308% 0.896% 
Japan 106.392% 18.150% 3.957% 2.711% 
Jordan 19.748% 3.370% 0.734% 0.502% 
Kazakhstan 38.039% 6.490% 1.416% 0.970% 
Kenya 9.247% 1.578% 0.345% 0.237% 
Kuwait 23.190% 3.956% 0.862% 0.592% 
Kyrgyzstan 19.650% 3.352% 0.732% 0.500% 
Laos 12.584% 2.147% 0.469% 0.322% 
Latvia 66.508% 11.347% 2.475% 1.696% 
Lebanon 29.199% 4.982% 1.088% 0.745% 
Liberia 8.083% 1.379% 0.301% 0.206% 
Lithuania 63.380% 10.812% 2.357% 1.615% 
Luxembourg 38.362% 6.544% 1.426% 0.978% 
Madagascar 10.940% 1.866% 0.406% 0.280% 
 23 
 
Malaysia 27.315% 4.659% 1.015% 0.695% 
Maldives 11.872% 2.026% 0.442% 0.303% 
Mali 9.117% 1.556% 0.339% 0.232% 
Malta 63.846% 10.893% 2.376% 1.628% 
Mauritania 16.562% 2.825% 0.616% 0.423% 
Mauritius 41.780% 7.127% 1.554% 1.065% 
Mexico 31.717% 5.411% 1.181% 0.809% 
Mongolia 19.201% 3.275% 0.716% 0.490% 
Montenegro 48.062% 8.199% 1.788% 1.225% 
Morocco 28.514% 4.864% 1.060% 0.728% 
Mozambique 14.593% 2.489% 0.542% 0.370% 
Myanmar 22.639% 3.863% 0.843% 0.579% 
Namibia 13.931% 2.377% 0.520% 0.356% 
Nepal 16.534% 2.820% 0.615% 0.422% 
Netherlands 69.913% 11.927% 2.602% 1.783% 
New Zealand 59.780% 10.199% 2.223% 1.524% 
Nicaragua 23.104% 3.941% 0.860% 0.589% 
Niger 10.385% 1.772% 0.386% 0.264% 
Nigeria 16.821% 2.870% 0.626% 0.429% 
Norway 76.721% 13.088% 2.854% 1.957% 
Oman 14.295% 2.440% 0.532% 0.365% 
Pakistan 18.299% 3.122% 0.680% 0.465% 
Panama 26.965% 4.601% 1.004% 0.689% 
Papua New Guinea 12.876% 2.196% 0.479% 0.328% 
Paraguay 19.639% 3.351% 0.731% 0.501% 
Peru 31.019% 5.293% 1.155% 0.791% 
Philippines 26.605% 4.540% 0.991% 0.679% 
Poland 61.086% 10.421% 2.272% 1.556% 
Portugal 77.183% 13.168% 2.870% 1.968% 
Puerto Rico 48.958% 8.353% 1.821% 1.248% 
Qatar 15.025% 2.563% 0.558% 0.383% 
Republic of Korea 55.566% 9.480% 2.067% 1.417% 
Romania 55.837% 9.526% 2.077% 1.424% 
Russian Federation 60.353% 10.296% 2.245% 1.539% 
Rwanda 12.450% 2.124% 0.464% 0.318% 
Saint Lucia 28.497% 4.861% 1.060% 0.726% 
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Saint Vincent and the 
Grenadines 
35.610% 6.076% 1.325% 0.909% 
Saudi Arabia 17.916% 3.058% 0.667% 0.458% 
Senegal 8.614% 1.468% 0.320% 0.219% 
Serbia 52.158% 8.898% 1.940% 1.329% 
Seychelles 31.571% 5.387% 1.175% 0.804% 
Singapore 41.928% 7.153% 1.560% 1.069% 
Slovakia 55.778% 9.516% 2.075% 1.422% 
Slovenia 66.649% 11.371% 2.479% 1.700% 
South Africa 21.798% 3.719% 0.810% 0.556% 
Spain 75.447% 12.871% 2.806% 1.924% 
Sri Lanka 39.536% 6.745% 1.470% 1.007% 
Sudan 30.755% 5.248% 1.146% 0.788% 
Suriname 45.109% 7.697% 1.681% 1.152% 
Sweden 81.599% 13.920% 3.036% 2.080% 
Switzerland 76.923% 13.124% 2.861% 1.960% 
Thailand 41.037% 7.002% 1.527% 1.047% 
Timor Leste 19.297% 3.291% 0.717% 0.492% 
Togo 10.248% 1.748% 0.381% 0.261% 
Trinidad and Tobago 45.967% 7.842% 1.710% 1.172% 
Tunisia 41.612% 7.098% 1.547% 1.061% 
Turkey 38.306% 6.534% 1.425% 0.975% 
Uganda 10.105% 1.722% 0.375% 0.257% 
Ukraine 58.496% 9.979% 2.175% 1.492% 
United Arab Emirates 11.495% 1.962% 0.429% 0.294% 
United Kingdom 73.183% 12.485% 2.721% 1.865% 
United States of 
America 
34.365% 5.863% 1.277% 0.875% 
Uruguay 54.630% 9.319% 2.032% 1.391% 
Uzbekistan 30.747% 5.246% 1.145% 0.786% 
Vietnam 26.600% 4.538% 0.990% 0.679% 
Zambia 9.717% 1.660% 0.363% 0.249% 
Zimbabwe 5.267% 0.898% 0.196% 0.135% 
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